Johnson & Johnson (JNJ) Declined Amid Broad Sell-Off in Healthcare
In its second quarter 2025 investor letter, Mar Vista U.S. Quality Premier Strategy highlighted stocks such as Johnson & Johnson (NYSE:JNJ). Johnson & Johnson (NYSE:JNJ) is a multinational company that engages in the research, development, and manufacturing of products in the healthcare field. The one-month return of Johnson & Johnson (NYSE:JNJ) was 0.38%, and its shares gained 5.21% of their value over the last 52 weeks. On July 10, 2025, Johnson & Johnson (NYSE:JNJ) stock closed at $157.69 per share, with a market capitalization of $382.837 billion.
Mar Vista U.S. Quality Premier Strategy stated the following regarding Johnson & Johnson (NYSE:JNJ) in its second quarter 2025 investor letter:
"Johnson & Johnson (NYSE:JNJ) declined 7% during the quarter amid a broad selloff in healthcare which led to the sector's worst relative performance in twenty-five years. Proposed regulatory changes and tariffs impacting drug prices, research and development investments, manufacturing and insurance coverage all converged to create uncertainty for the sector. JNJ also suffered a setback to put talc liabilities behind them when a Texas court ruled the company's bankruptcy strategy was not allowed. The company will return to litigating lawsuits in the courts, where the company has won 15 out of 16 cases."
A smiling baby with an array of baby care products in the foreground.
Johnson & Johnson (NYSE:JNJ) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 91 hedge fund portfolios held Johnson & Johnson (NYSE:JNJ) at the end of the first quarter, compared to 98 in the previous quarter. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In another article, we covered Johnson & Johnson (NYSE:JNJ) and shared the list of most undervalued NYSE stocks to buy. In the previous quarter, Mar Vista U.S. Quality Select Strategy attributed Johnson & Johnson's (NYSE:JNJ) rise to strong fundamentals and favorable market sentiment. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Amazon Founder Jeff Bezos Loses $17 Billion Following Company's Mixed Q2 Earnings
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Jeff Bezos, the founder and Executive Chairman of Inc. (NASDAQ:AMZN), saw his net worth take a plunge, alongside the shares of his company, following its second quarter results last week. What Happened: The fourth-richest man in the world, with a net worth of $237 billion, according to the Bloomberg Billionaires Index, lost $17 billion last week on Friday, from $254 billion the prior day, after investors were unimpressed with the company's second-quarter earnings. The stock was down 8.27% on Friday, following the company's results, despite it beating consensus estimates on sales and earnings. Don't Miss: 7,000+ investors have joined Timeplast's mission to eliminate microplastics— This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — You Can Become an Investor for Just $500.25 This was largely attributed to the slowing momentum in the company's AWS cloud computing segment, which generated $10.2 billion in sales during the quarter, up 17.5% year-over-year, which fell short of consensus estimates at 20%. Amazon shares currently constitute a significant chunk of Bezos' net worth, with 884 million shares, or 8.3% of total shares outstanding, which, at the stock's current market price, is valued at $190 billion. The rest of his fortune comprises Blue Origin, his space exploration company, which, being privately held, is valued at the cost of investment. Why It Matters: According to analyst Eric Allen of Stealth, the market's reaction to the company's earnings was 'totally wrong,' since this was a capacity issue, with Amazon unable to meet the growing demand for its AWS computing resources. Amazon reported $167.7 billion in sales during the quarter, up 13% year-over-year, and ahead of consensus estimates at $161.9 billion. It posted a profit of $1.68 per share, which again beat analyst consensus estimates at $1.30. Bezos has been consistently offloading his stake in the company he founded, having sold 95 million shares in 2024 and 2025 so far, with net proceeds of $18.2 billion. Read More: $100k+ in investable assets? Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes – no cost, no obligation. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo courtesy: Shutterstock This article Amazon Founder Jeff Bezos Loses $17 Billion Following Company's Mixed Q2 Earnings originally appeared on Sign in to access your portfolio

Yahoo
3 minutes ago
- Yahoo
New marketing coordinator at Discover Kalispell steps into role
Aug. 4—For Annie Young, using professional skills to impact a community in a positive way is one of the best things about working in the marketing industry. Entering her new role as marketing communications manager of Discover Kalispell, Young looks forward to doing just that. "I'm inspired by this place, the joy it brings me personally and the opportunity to help others," Young said last week. "Seeing this team at Discover Kalispell do that day in and day out ... I'm thrilled to be a part of that." As the marketing communications manager, Young is responsible for the development and supervision of marketing and communication strategies, including working with agency partners to amplify the brand presence, continue to build out email marketing, managing the website and designing promotional products. Growing up, Young spent her childhood moving and traveling across the country as her father served in the Air Force. She attended the University of Arkansas, where she majored in journalism, advertising and public relations, and officially landed in the Flathead Valley about five years ago. Prior to moving to the valley, Young would often visit the region, enjoying the mountains and clear blue lakes. With the knowledge and experience of being a visitor to now having a local perspective, Young is uniquely positioned to amplify Discover Kalispell's voice. "I'm really excited to continue the work that's being done here and build on that. Specifically making sure Kalispell is positioned as an opportunity to experience Montana authentically," Young said. Prior to joining Discover Kalispell, Young spent 10 years as the marketing and communications director for Central Washington University Advancement, where she worked on the college's branding, design, marketing, merchandising and production. She looks forward to using the skills she's acquired over the years in a new way that works with the local business community. "The goal is to make sure we're supporting tourism in a way that supports local businesses but also preserves the way of life here," she said. Young, her husband Derek and her son Dillon live in the Flathead Valley. Her daughter, Sydney, lives in Lolo. Young officially started at Discover Kalispell at the end of June. Discover Kalispell is Kalispell's marketing organization that manages a sales and promotion strategy while working closely with the Kalispell Chamber of Commerce and the business community. A fun opportunity for visitors and residents both is the Huckleberry Treat Trail challenge through Discover Kalispell, Young said. The challenge includes a list of savory and sweet drinks and meals across the valley that includes huckleberries. Those who check in at the stops can earn points for a chance to win prizes. To learn more, visit Reporter Kate Heston may be reached at 758-4459 or kheston@ Solve the daily Crossword
Yahoo
3 minutes ago
- Yahoo
Wall Street thinks the party for Palantir can continue even after a wild rally in 2025 — but there's one key risk
Palantir is the top-performing stock in the S&P 500 this year, and Wall Street is upbeat about what's ahead. Palantir has been on a tear, climbing 113% since the start of the year. A lofty valuation is the main risk analysts are eyeing heading into second-quarter earnings. Wall Street thinks the Palantir party can keep going. The stock is already up by about 113% this year as it heads into its second-quarter earnings report after the bell on Monday, but analysts see reasons to believe the gains can pile up further. The Alex Karp-led software giant is benefiting from a slew of government contracts, roaring AI demand, and a cultlike following among retail investors in 2025. Shares of the company have soared from around $75 a share at the start of 2025 to above $160 on Monday. That ascent has made Palantir the best-performing stock in the S&P 500 this year. Analysts are bullish about Palantir's second-quarter earnings. They estimate the tech giant will report $939.3 million in revenue for the three-month period, up around 38% year over year. Here are some of the reasons they see the growth story continuing — and one key risk. 1. The AI trade is still running hot Palantir will likely keep up growth in its commercial segment, thanks to the ongoing hype surrounding AI. Accelerating AI adoption is creating a greater need to integrate data, which is good news for the stock, analysts at Mizuho wrote in a note. The bank said it conducted checks on Palantir's enterprise inbound activity, which gave it confidence that the company would be able to beat its commercial growth guidance in 2025. Palantir expects the US commercial side of its business to grow 68% for the year. "PLTR's recent execution and momentum is stunning, including material upward revisions across its commercial and government segments that we very much underestimated," Mizuho analysts wrote. Analysts at UBS said they also conducted checks on Palantir's enterprise businesses, and lifted their estimates for the company's revenue growth from 31% to 38% for the year. "We see potential tailwinds from the increasing adoption of AI across enterprise," Citi analysts wrote, adding that its checks and its conversation with Palantir's chief finance officer were also positive. Government contracts A large part of Palantir's growth story has been fueled by its contracts with the federal government. In April, the software company secured a $30 million deal with the US Immigration and Customs Enforcement for software to monitor visas and track deportations. In May, the firm teamed up with Fannie Mae, and said it would provide AI tools to support the government-sponsored mortgage financier's Crime Detection Unit. It also secured a $795 million contract with the Department of Defense's AI arm, and last week, locked a deal to help streamline the US Army for up to $10 billion for the next decade. The deal consolidates 75 existing contracts into a single agreement. "We believe this deal represents an additional tailwind for PLTR with AI initiatives across the US government accelerating with AI a strategic focus on the federal front and Palantir in the sweet spot to benefit from a tidal wave of federal spending on AI," analysts at Wedbush Securities wrote last week, calling Palantir one of the top tech stocks to own in 2025. "We remain positive on the public sector pipeline, which appears durable given ongoing geopolitical instability. Net, we believe PLTR will likely be able to continue growing its Government revenue >40% Y/Y over at least the near-term," Mizuho said. "We continue to view Palantir as well positioned to continue to deliver best-in-class growth given the secular trend towards enterprise AI adoption; the continued push for efficiency and technology adoption in the US government; and adoption of Operation Warp Speed among new defense entrants, traditional defense companies, and the broader manufacturing industry," analyst at Goldman Sachs wrote in a note following Palantir's first-quarter earnings report in May. High bar But there's one risk Wall Street is eyeing: the valuation is at eye-watering levels. As of Monday afternoon, the trailing 12-month price-to-earnings ratio was above 690x. Despite a bullish short-term outlook, Goldman Sachs, UBS, and Mizuho are among those on Wall Street who rated Palantir as "neutral" headed into its second-quarter earnings. Analysts at Citi, meanwhile, rated the stock as "Neutral/High Risk." "We maintain our Neutral/High Risk rating on the stock on valuation concerns and our view that second derivative/revision trends could moderate limiting upside," Citi added in a note. "That said, we are equally stunned by the multiple that PLTR has attained, which places its valuation dramatically above anything else in software," Mizuho analysts said, adding they would "continue to worry" that the stock could see a reversion sometime in the next several quarters. "We continue to be very impressed by the fundamental story (we have been since our launch) but valuation remains our key hurdle, we remain Neutral rated," UBS said. Read the original article on Business Insider Sign in to access your portfolio